443 related articles for article (PubMed ID: 17407516)
1. Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride.
Hahn RG; Fagerström T; Tammela TL; Van Vierssen Trip O; Beisland HO; Duggan A; Morrill B
BJU Int; 2007 Mar; 99(3):587-94. PubMed ID: 17407516
[TBL] [Abstract][Full Text] [Related]
2. [Effect of dutasteride on reduction of intraoperative bleeding related to transurethral resection of the prostate].
Boccon-Gibod L; Valton M; Ibrahim H; Boccon-Gibod L; Comenducci A
Prog Urol; 2005 Dec; 15(6):1085-9. PubMed ID: 16429657
[TBL] [Abstract][Full Text] [Related]
3. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
[TBL] [Abstract][Full Text] [Related]
4. Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates.
Busetto GM; Giovannone R; Antonini G; Rossi A; Del Giudice F; Tricarico S; Ragonesi G; Gentile V; De Berardinis E
BJU Int; 2015 Jul; 116(1):117-23. PubMed ID: 25291499
[TBL] [Abstract][Full Text] [Related]
5. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
6. Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate.
Tuncel A; Ener K; Han O; Nalcacioglu V; Aydin O; Seckin S; Atan A
Scand J Urol Nephrol; 2009; 43(5):377-82. PubMed ID: 19921983
[TBL] [Abstract][Full Text] [Related]
7. The effect of dutasteride on the efficacy of photoselective vaporization of the prostate: results of a randomized, placebo-controlled, double-blind study (DOP trial).
Bepple JL; Barone BB; Eure G
Urology; 2009 Nov; 74(5):1101-4. PubMed ID: 19800668
[TBL] [Abstract][Full Text] [Related]
8. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
[TBL] [Abstract][Full Text] [Related]
9. Transurethral Resection of Prostate and Bleeding: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial to See the Efficacy of Short-Term Use of Finasteride and Dutasteride on Operative Blood Loss and Prostatic Microvessel Density.
Bansal A; Arora A
J Endourol; 2017 Sep; 31(9):910-917. PubMed ID: 28650680
[TBL] [Abstract][Full Text] [Related]
10. Preoperative administration of chlormadinone acetate reduces blood loss associated with transurethral resection of the prostate: a prospective randomized study.
Ukimura O; Kawauchi A; Kanazawa M; Miyashita H; Yoneda K; Kojima M; Nakanouchi T; Miki T;
BJU Int; 2005 Jul; 96(1):98-102. PubMed ID: 15963129
[TBL] [Abstract][Full Text] [Related]
11. Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.
Andriole GL; Humphrey P; Ray P; Gleave ME; Trachtenberg J; Thomas LN; Lazier CB; Rittmaster RS
J Urol; 2004 Sep; 172(3):915-9. PubMed ID: 15310997
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia.
Debruyne F; Barkin J; van Erps P; Reis M; Tammela TL; Roehrborn C;
Eur Urol; 2004 Oct; 46(4):488-94; discussion 495. PubMed ID: 15363566
[TBL] [Abstract][Full Text] [Related]
13. Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications.
Berger AP; Wirtenberger W; Bektic J; Steiner H; Spranger R; Bartsch G; Horninger W
J Urol; 2004 Jan; 171(1):289-91. PubMed ID: 14665896
[TBL] [Abstract][Full Text] [Related]
14. [The effect of Yunnan Baiyao on reduction of intra-operative bleeding of the patients undergoing transurethral resection of prostate].
Li NC; Pan BN; Wang HJ; Li HZ; Wei Q; Wang XH; Cai SL; Gan WM; Na YQ
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1017-20. PubMed ID: 17672962
[TBL] [Abstract][Full Text] [Related]
15. Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss.
Pastore AL; Mariani S; Barrese F; Palleschi G; Valentini AM; Pacini L; Petrozza V; Carbone A; Cappa M
J Endourol; 2013 Jan; 27(1):68-70. PubMed ID: 23030716
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term dutasteride therapy on prostate vascularity in patients with benign prostatic hyperplasia: a pilot study.
Kravchick S; Cytron S; Mamonov A; Peled R; Linov L
Urology; 2009 Jun; 73(6):1274-8. PubMed ID: 19375786
[TBL] [Abstract][Full Text] [Related]
17. Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.
Zhu YP; Dai B; Zhang HL; Shi GH; Ye DW
BMC Urol; 2015 Jun; 15():47. PubMed ID: 26032962
[TBL] [Abstract][Full Text] [Related]
18. Transurethral resection of the prostate after intraprostatic injections of mepivacain epinephrine: a preliminary communication.
Schelin S
Scand J Urol Nephrol; 2009; 43(1):63-7. PubMed ID: 19085323
[TBL] [Abstract][Full Text] [Related]
19. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
Botto H; Lan O; Poulain JE; Comenducci A
Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic efficacy of bipolar plasmakinetic technique compared with transurethral resection on benign prostate hyperplasia].
Wu WJ; Wang XH; Wang HP; Zou WB; Liang XY; Cai ZG; Zhong WW; Zou YF; Yuan DZ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3365-7. PubMed ID: 16409848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
